Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Arenas-Ramirez

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Swiss Medical Weekly|January 24, 2019
Development of a novel class of interleukin-2 immunotherapies for metastatic cancerOnur Boyman, Natalia Arenas-Ramirez
ACS Chemical Biology|June 10, 2009
Imaging the lipidome: omega-alkynyl fatty acids for detection and cellular visualization of lipid-modified proteinsRami N Hannoush, Natalia Arenas-Ramirez
Trends in Immunology|November 18, 2015
Interleukin-2: Biology, Design and ApplicationNatalia Arenas-Ramirez, Janine Woytschak, Onur Boyman
Cellular and Molecular Life Sciences : CMLS|August 25, 2018
Epigenetic mechanisms of tumor resistance to immunotherapyNatalia Arenas-Ramirez, Dilara Sahin, Onur Boyman
The Journal of Allergy and Clinical Immunology|November 12, 2016
Endogenous polyclonal anti-IL-1 antibody responses potentiate IL-1 activity during pathogenic inflammationGunther Spohn, Natalia Arenas-Ramirez, Gregory Bouchaud, et al.
FEBS Letters|July 12, 2011
Membrane targeting of palmitoylated Wnt and Hedgehog revealed by chemical probesXinxin Gao, Natalia Arenas-Ramirez, Suzie J Scales, et al.
Current Opinion in Chemical Biology|October 2, 2014
Use of enhanced interleukin-2 formulations for improved immunotherapy against cancerRodney A Rosalia, Natalia Arenas-Ramirez, Grégory Bouchaud, et al.
Nature Communications|December 23, 2020
An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancerDilara Sahin, Natalia Arenas-Ramirez, Matthias Rath, et al.
Cell Reports|July 27, 2017
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor ImmunotherapyDaniel Zingg, Natalia Arenas-Ramirez, Dilara Sahin, et al.
Science Translational Medicine|December 2, 2016
Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2Natalia Arenas-Ramirez, Chao Zou, Simone Popp, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Swiss Medical Weekly|January 24, 2019
Development of a novel class of interleukin-2 immunotherapies for metastatic cancerOnur Boyman, Natalia Arenas-Ramirez
ACS Chemical Biology|June 10, 2009
Imaging the lipidome: omega-alkynyl fatty acids for detection and cellular visualization of lipid-modified proteinsRami N Hannoush, Natalia Arenas-Ramirez
Trends in Immunology|November 18, 2015
Interleukin-2: Biology, Design and ApplicationNatalia Arenas-Ramirez, Janine Woytschak, Onur Boyman
Cellular and Molecular Life Sciences : CMLS|August 25, 2018
Epigenetic mechanisms of tumor resistance to immunotherapyNatalia Arenas-Ramirez, Dilara Sahin, Onur Boyman
The Journal of Allergy and Clinical Immunology|November 12, 2016
Endogenous polyclonal anti-IL-1 antibody responses potentiate IL-1 activity during pathogenic inflammationGunther Spohn, Natalia Arenas-Ramirez, Gregory Bouchaud, et al.
FEBS Letters|July 12, 2011
Membrane targeting of palmitoylated Wnt and Hedgehog revealed by chemical probesXinxin Gao, Natalia Arenas-Ramirez, Suzie J Scales, et al.
Current Opinion in Chemical Biology|October 2, 2014
Use of enhanced interleukin-2 formulations for improved immunotherapy against cancerRodney A Rosalia, Natalia Arenas-Ramirez, Grégory Bouchaud, et al.
Nature Communications|December 23, 2020
An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancerDilara Sahin, Natalia Arenas-Ramirez, Matthias Rath, et al.
Cell Reports|July 27, 2017
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor ImmunotherapyDaniel Zingg, Natalia Arenas-Ramirez, Dilara Sahin, et al.
Science Translational Medicine|December 2, 2016
Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2Natalia Arenas-Ramirez, Chao Zou, Simone Popp, et al.
Pageof 2